HAMBURG, Germany, Jan. 20, 2011 (GLOBE NEWSWIRE) — Evotec AG (Frankfurt:EVT) today announced that it has entered into a collaboration with Takeda Cambridge Limited, to identify small molecule modulators against GPCR and Protease targets involved in various CNS and Metabolic diseases.
Evotec will apply its state-of-the-art Screening Platform and proprietary GPCR modeling software to identify and [...] http://bit.ly/e3t5ot
No comments:
Post a Comment